These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 722715)

  • 1. Synthesis of potential hypolipidemic agents. Reaction of substituted phenyl 2,3-epoxypropyl ethers with adenine, uracil, and thymine.
    DiMenna WS; Piantadosi C; Lamb RG
    J Med Chem; 1978 Oct; 21(10):1073-6. PubMed ID: 722715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 4,6-dideoxy-3-fluoro-2-keto-beta-D-glucopyranosyl analogues of 5-fluorouracil, N6-benzoyl adenine, uracil, thymine, N4-benzoyl cytosine and evaluation of their antitumor activities.
    Manta S; Tsoukala E; Tzioumaki N; Kiritsis C; Balzarini J; Komiotis D
    Bioorg Chem; 2010 Apr; 38(2):48-55. PubMed ID: 20018340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor agents. 25. Synthesis and antitumor activity of uracil and thymine alpha-methylene-gamma-lactones and related derivatives.
    Lee KH; Wu YS; Hall IH
    J Med Chem; 1977 Jul; 20(7):911-4. PubMed ID: 874966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Janus-AT bases: synthesis, self-assembly, and solid state structures.
    Asadi A; Patrick BO; Perrin DM
    J Org Chem; 2007 Jan; 72(2):466-75. PubMed ID: 17221963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolipidemic activity of 5-aryl-3-methylvaleric acid derivatives.
    Dygos JH; Jett CM; Chinn LJ; Miller JE
    J Med Chem; 1977 Dec; 20(12):1705-8. PubMed ID: 592342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypolipidemic activity of substituted 2-pyrrolidinones in rodents.
    Cocolas GH; Chapman JM; Voorstad PJ; Hall IH
    J Pharm Sci; 1983 Jul; 72(7):812-4. PubMed ID: 6886988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and hypolipidemic activity of N-substituted phthalimides. Part V.
    Sena VL; Srivastava RM; Silva RO; Lima VL
    Farmaco; 2003 Dec; 58(12):1283-8. PubMed ID: 14630240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidemic activity of 6-substituted 6,7-dihydro-5H-dibenz[c,e]azepine and the effects of 6,7-dihydro-5H-dibenz[c,e]azepine on lipid metabolism of rodents.
    Hall IH; Murthy AR; Wyrick SD
    J Pharm Sci; 1986 Jun; 75(6):622-6. PubMed ID: 3735111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and binding property of isoelectronic analogues of nucleobases, B(6)-substituted 5-aza-6-borauracils and -thymines.
    Ito H; Yumura K; Saigo K
    Org Lett; 2010 Aug; 12(15):3386-9. PubMed ID: 20586441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity.
    Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E
    Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
    Chrysselis MC; Rekka EA; Kourounakis PN
    J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidemic activity of in vitro inhibitors of hepatic and intestinal sn-glycerol-3-phosphate acyltransferase and phosphatidate phosphohydrolase.
    Lamb RG; Wyrick SD; Piantadosi C
    Atherosclerosis; 1977 Jun; 27(2):147-54. PubMed ID: 197974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives.
    Moriya T; Takabe S; Maeda S; Matsumoto K; Takashima K; Mori T; Takeyama S
    J Med Chem; 1986 Mar; 29(3):333-41. PubMed ID: 3950914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidemic activity of 4-substituted 1,2-diacyl-1,2,4-triazolidine-3,5-diones in rodents.
    Simlot R; Izydore RA; Wong OT; Hall IH
    J Pharm Sci; 1994 Mar; 83(3):367-71. PubMed ID: 8207683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues.
    Meng G; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):779-89. PubMed ID: 12843582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Highly Substituted Imidazole Uracil Containing Molecules via Ugi-4CR and Passerini-3CR.
    Madhavachary R; Zarganes-Tzitzikas T; Patil P; Kurpiewska K; Kalinowska-Tłuścik J; Dömling A
    ACS Comb Sci; 2018 Apr; 20(4):192-196. PubMed ID: 29457887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified bases in bacteriophage DNAs.
    Warren RA
    Annu Rev Microbiol; 1980; 34():137-58. PubMed ID: 7002022
    [No Abstract]   [Full Text] [Related]  

  • 18. Antilipidemic agents, Part. IV: Synthesis and antilipidemic testing of some heterocyclic derivatives of hexadecyl and cyclohexyl hemisuccinate esters.
    Habib NS; Ismail KA; el-Tombary AA; Abdel Aziem T
    Pharmazie; 2000 Jul; 55(7):495-9. PubMed ID: 10944775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on hypolipidemic agents. I. 3-Benzoylglycidic acid derivatives.
    Tomisawa K; Kameo K; Goi M; Sota K
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3066-74. PubMed ID: 6518588
    [No Abstract]   [Full Text] [Related]  

  • 20. Dipole moments of 2,4-diketopyrimidines. II. Uracil, thymine and their derivatives.
    Kulakowska I; Geller M; Lesyng B; Wierzchowski KL
    Biochim Biophys Acta; 1974 Aug; 361(2):119-30. PubMed ID: 4479091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.